at 5.09 Baht per share). The result of the transaction is the Company will no longer hold any TSE shares. 8. Expected benefits Disposal sales of the assets will return a cash proceeds of 925.11 Million

the increases in revenue. Gross Profit and Gross Profit Margin (GPM) in Q4/18, the Company has gross profit from sales of real estate of THB 344.6mn, or GPM of 25.4%, which decreased from GPM of 36.0

For the nine-month period ended 30 September 2019, the Company had revenue from program rights of THB 1,264.97 million which was composed of domestic sales amounting to THB 862.88 million and export

overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative

with the cost of sales in 1Q19. Such decrease was in line with a decrease in sales volume. In 1H19, the Company recorded the cost of sales in the amount of Baht 323.41 million which decreased by Baht

equipment business has been operated by the Company and Spacemed Company Limited (subsidiary). Revenues from sales and services from distributor of medical devices and equipment at the first quarter was THB

of medical devices and equipment business has been operated by the Company and Spacemed Company Limited (subsidiary). Revenues from sales and services from distributor of medical devices and equipment

medical devices and equipment business has been operated by the Company and Spacemed Company Limited (subsidiary). Revenues from sales and services from distributor of medical devices and equipment at the

expanding through TV media and online channels. This is the core business of Shop Global (Thailand) Ltd. that the Company has invested in. And this will be another sales channel for expanding market and sales

the same period in 2018. The decrease in revenue resulted mainly from the decline of revenues from the manufacturing and selling of Special Cutting Tools segment, which include sales from the Company